Downloaded from jarums.arums.ac.ir at 22:00 IRDT on Friday March 22nd 2019
|
|
|
- Bethanie Curtis
- 5 years ago
- Views:
Transcription
1 ﻣ Research & Scientific Journal of Ardabil University of Medical Sciences & Health Services Vol 2, No 8, Jun-Sep 2003 ﺳﻜﺘﻪ ) ( ﺧﻄﺮ ﻣﺨﺘﻠﻒ ﺷﺎﻣﻞ ﻗﺮ ﻧﺴﺨﻪ SPSS ﻳﺎﻓﺘﻪ ﻫﺎ (OR=٥/٤ %٥ CI=/ -٥/) ﺣﺎﺻﻞ ﺷﺪ p=٠/٠٥ ( ﺑﺎ %٥ CI=٠/٥-٧/) /٧
2 ﻣﺠﻠﻪ ﻋﻠﻤﻲ ۴۶ ﻣﻘﺪﻣﻪ WHO ﻣﻄﺎﻟﻌﻪ [٥ ] () (Case Reports) ٠[ ] ٥٠ [٥ ٠] ٦٠ ٠٠ ﺗﺎ ٨٠ ٧٠ ٥٠ ٧٠ ٨ [ -٨] ﻧﺘﺎﻳﺞ ﻣﺘﻐﻴﺮ [٠ ] ٠٠ ﻫﻤﭽﻨﻴﻦ ﻣﻄﺎﻟﻌﻪ ﺳﻴﺮﻳﺘﻮ [] ﻧﺴﺨﻪ SPSS [٤ ] 1- Oral Contraceptives 2-Sirtho
3 ۴۷ (%٥/٤) ﻧﻔﺮ (%٤/) ﻧﻔﺮ ٦ ﻳﺎﻓﺘﻪ ﻫﺎ ﺷﺎﻫﺪ ٧ ﺷﺎﻫﺪ ﻫﺎ ٨/٧ ٤ ٧ ٤ ٦/ ٨ ﻣﺼﺮﻓﻲ ٦/٥ ٨ ٧/٥ / /٥ HD /٤ ٨ ٥ ٠ ٠ / ٧ ٦ (%٥) ﻧﺎ ﻣﺸﺨﺺ ﺳ ٦٠/٦ (%/٦) ٥٥ %/ () ﻫﻤﺎﻧﮕﻮﻧﻪ ﻛﻪ ﻣﺸﺨﺺ (OR=٨/٦ OR=) ٦ ﻫﻤﭽﻨﻴﻦ (%٨/٧) ﻧﻔﺮ ٤ ﺮ ﺳﻜﺘﻪ =/٤ ( (%) ﻧﻔـﺮ ﺣﺎﺻﻞ ﺷﺪ CI=/-٥/ ﺑﺎ OR ) ٧ ﻣﺼﺮﻓﻲ ﻲ ﺷﺎﻫﺪ ﻫﺎ %٦/ HD ٥/٤ ٦٦/٧ ٦ ٨٤/٦ / ٨ ٧/٧ ٥ ٦ / ٧٥ ٨ / ٧/٥ ٧٦/ ٠ ٦/٥ ٥ ﺣﺎﺻﻞ ﻧﻴﺎﻣﺪ ٥ ٧ /٥ (%٤٨/٦) ﻧﻔﺮ ٨ ﻣﻌ
4 ﻣﺠﻠﻪ ﻋﻠﻤﻲ ۴۸ /٨ /٤ [] OR= /٧ HD ﺷﺎﻣﻞ ﺣﺎﺻﻞ ﺷﺪ p=٠/٠٥ ( ﺑﺎ CI=٠/٥-٧/) ﺑﺤﺚ HD ٧٠ ٦٠ [-٨] [٦ ٠ ٤ ] WHO ٧٠ [٧ -] ٨٠-٠٠ ٧٠ ٦٠ ٥٠ ﺗﺎ WHO ﻣﻄﺎﻟﻌﻪ ﺣﺎﺿﺮ [٥ ] ٤/٥ (CI=/٥-٦/) OR= (CI=/٦ -/٨) ﻣﺼﺮﻓﻲ OR=٨/٦ ﺷﺎﻧﺲ /٤ OR=/٧ OR=/٦ (CI=/-٦/٤) /٨ ٤ ﻛﻨ [٤] ﺳﺎﻟﻪ ٤-٤٤ 1- Lidegaard p=٠/٠٥ 2- Petitti ٤٠٨ ﭘﺘﻴﺘﻲ
5 ۴۹ 1-Jordan WM Pulmonary embolism Lancet 1961; Lorentz IT Parietal lesion and Enovid BMJ 1962; Inman WH, Vessey MP Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of childbearing age Br Med J 1968 Apr; 2(599) Vessey MP, Doll RInvestigation of relation between use of oral contraceptives and thromboembolic disease Br Med J 1968 Apr; 2(599) Startwell PE, Masi AT, Arthes FG, Greene GR, Smith HE Thromboembolic and oral contraceptives an epidemiological case-ontrol study Am J Epidemiol 1969; 90(5) Oral contraceptive and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumors report from the Boston Collaborative Drug Surveillance Program Lancet 1973; Sartwell PE Oral contraceptives and thromboembolism a further report Am J Epidemiol 1971 Sep; 94(3) Collaborative Group for the Study of Stroke in Young Women Oral contraception and increased risk of cerebral ischemia or thrombosis N Engl J Med 1973; Vessey MP, Lawless M, Yeates D Oral contraceptives and nonfatal stroke in healthy young women Annals of Internal Med 1989; (88) Hannaford PC, Croft PR, Kay CR Oral contraception and stroke Evidence from the Royal College of General Practitioners' Oral Contraception Study Stroke 1994 May; 25(5) Siritho S, Thrift AG, McNeil JJ, You RX, Davis SM, Donnan GA, et al Risk of ischemic stroke among users of the oral contraceptive pill The Melbourne Risk Factor Study Group Stroke 2003 Jul; 34(7) Petitti DB, Sidney S, Bernstein A, Wolf SH, Quesenberry C, Ziel HK Stroke in users [٠ ] ﮔﺬﺷﺘﻪ ﻣﻨﻘﻄﻊ [٤ ] ٥ ٧/٥ (p < ٠/٠٥) [٨ ٧ ٥] ﻫﺮ ﭼﻨﺪ ﻧﺘﺎﻳﺞ ﻣﻨﺎﺑﻊ
6 ﻣﺠﻠﻪ ﻋﻠﻤﻲ ۵۰ of low-dose oral contraceptives N Engl J Med 1996 Jul; 335(1) WHO Collaborative Study of Cardiovascular Diseases and Steroidal Hormone Contraception Ischemic stroke and combined oral contraceptives vests of an International Multicenter case-control study Lancet 1996; Lidegaard O Oral contraception and risk of a cerebral thromboembolic attack results of a case-control study BMJ 1993 Apr; 306 (6883) Collaborative Group for the Study of stroke in young women Oral contraceptives and stroke in young women associated risk factors J Am Med Assoc 1975 Feb; 231(7) Inman WH, Vessey MP, Westerholm B, Engelund A Thromboembolic disease and the steroidal content of oral contraceptives A report to the Committee on Safety of Drugs Br Med J 1970 Apr; 2(703) Mann JI, Vessey MP, Thorogood M, Doll SR Myocardial infarction in young women with special reference to oral contraceptive practice Br Med J 1975 May; 2(5965) Mann JI, Inman WH Oral contraceptives and death from myocardial infarctionbr Med J 1975 May; 2(5965) Ory HW Association between oral contraceptives and myocardial infarction a review J Am Med Assoc 1977 June; 237(24)
STROKE IN USERS OF LOW-DOSE ORAL CONTRACEPTIVES. The New England Journal of Medicine
STROKE IN USERS OF LOW-DOSE ORAL CONTRACEPTIVES DIANA B. PETITTI, M.D., STEPHEN SIDNEY, M.D., ALLAN BERNSTEIN, M.D., SHELDON WOLF, M.D., CHARLES QUESENBERRY, PH.D., AND HARRY K. ZIEL, M.D. ABSTRACT Background
Original Contributions. Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill. The Melbourne Risk Factor Study (MERFS) Group
Original Contributions Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill The Melbourne Risk Factor Study (MERFS) Group Sasitorn Siritho, MD; Amanda G. Thrift, PhD; John J. McNeil, PhD;
Downloaded from jarums.arums.ac.ir at 7:13 IRST on Friday October 12th 2018
ﻣ Research & Scientific Journal of Ardabil University of Medical Sciences & Health Services ١٣٨٢ Vol 2, No 7,Mar- Jun 2003 ﻫﻔﺘﻢ ﺳ Downloaded from jarumsarumsacir at 7:13 IRST on Friday October 12th 2018
Risk of myocardial infarction, angina and stroke in users of oral contraceptives: an updated analysis of a cohort study
British Journal of Obstetrics and Gynaecology August 1998, Vol. 105, pp. 896896 Risk of myocardial infarction, angina and stroke in users of oral contraceptives: an updated analysis of a cohort study Jonathan
ORIGINAL INVESTIGATION. Risk of Stroke in Women Exposed to Low-Dose Oral Contraceptives
Risk of Stroke in Women Exposed to Low-Dose Oral Contraceptives A Critical Evaluation of the Evidence ORIGINAL INVESTIGATION Wee-Shian Chan, MD, FRCPC, MSc; Joel Ray, MD, FRCPC, MSc; Eugene K. Wai, MD;
RISK OF ISCHEMIC STROKE ASSOCIATED WITH LOW-DOSE ORAL CONTRACEPTIVE USE: A META-ANALYSIS
RISK OF ISCHEMIC STROKE ASSOCIATED WITH LOW-DOSE ORAL CONTRACEPTIVE USE: A META-ANALYSIS Dae Hyun Kim, MD, MPH 1, Joachim Bleys, MD, MPH 2, Marlis Gonzalez-Fernandez, MD 3, Rebecca Gottesman, MD 4 and
General practice. Abstract. Subjects and methods. Introduction. examining the effect of use of oral contraceptives on mortality in the long term.
Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners oral contraception study Valerie Beral, Carol Hermon, Clifford
Does low dose contraceptive pills increase stroke rate? A cross sectional study in North-West Iran
Original Article Does low dose contraceptive pills increase stroke rate? A cross sectional study in North-West Iran Mehdi Farhoudi 1, Ehsan Sharifipour 2, Hormoz Ayromlou 3, Saeed Charsouei 4, Elyar Sadeghihokmabadi
Health consequences of combined oral contraceptives
Health consequences of combined oral contraceptives Philip Hannaford Department of General Practice and Primary Care, Foresterhtll Health Centre, Aberdeen, UK Correspondence to Prof Philip Hannaford, Department
Concern about the potential increased risk of cardiovascular
Myocardial Infarction and Use of Low-Dose Oral Contraceptives A Pooled Analysis of 2 US Studies Stephen Sidney, MD, MPH; David S. Siscovick, MD, MPH; Diana B. Petitti, MD, MPH; Stephen M. Schwartz, PhD,
ORIGINAL INVESTIGATION
ORIGINAL INVESTIGATION Risk of Venous With Use of Current Low-Dose Oral Contraceptives Is Not Explained by Diagnostic Suspicion and Referral Bias Kitty W. M. Bloemenkamp, MD; Frits R. Rosendaal, MD; Harry
7 TI - Epidemiology of intracerebral hemorrhage.
1 TI - Multiple postoperative intracerebral haematomas remote from the site of craniotomy. AU - Rapana A, et al. SO - Br J Neurosurg. 1998 Aug;1():-8. Review. IDS - PMID: 1000 UI: 991958 TI - Cerebral
HORMONE REPLACEMENT THERAPY
TRIALS OF HR RUTH (Barrett- Connor et al 29 ) JULY 2006 (Country) mean ± sd, range International trial 67.5 an Placebo component in 67.5 ± 6.7 women with Raloxifene or multiple 67.5 ± 6.6 risk factors
Contraccezione e tromboembolismo venoso
Contraccezione e tromboembolismo venoso Ida Martinelli Centro Emofilia e Trombosi Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico - Milano XXVII Congresso Nazionale FCSA Milano, 20-22.10.2016
on oral contraceptive safety and the contributions of KP research on hormonal contraception in the subsequent
Women s Health Four Decades of Research on Hormonal Contraception Introduction The first hormonal contraceptive was approved for marketing in the United States in 1960. This contraceptive, known then and
Supplementary Table 4. Study characteristics and association between OC use and endometrial cancer incidence
Supplementary Table 4. characteristics and association between OC use and endometrial cancer incidence a Details OR b 95% CI Covariates Region Case-control Parslov, 2000 (1) Danish women aged 25 49 yr
Risk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare
Risk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare New data A paper published in May 2012 in the British Medical Journal
Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Study. Oral Contraceptives and the Risk of Ischemic Stroke
Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Study Oral Contraceptives and the Risk of Ischemic Stroke Jeanet M. Kemmeren, PhD; Bea C. Tanis, MD; Maurice A.A.J. van den Bosch,
HRT and bone health. Management of osteoporosis and controversial issues. Delfin A. Tan, MD
Strong Bone Asia V. Osteoporosis in ASEAN (+), Danang, Vietnam, 3 August 2013 Management of osteoporosis and controversial issues HRT and bone health Delfin A. Tan, MD Section of Reproductive Endocrinology
The randomized study of efficiency and safety of antithrombotic therapy in
.. [ ] 18 150 160 mg/d 2 mg/d INR 2.0 3.0( 75 INR 1.6 2.5) 704 369 335 420 59.7% 63.3 9.9 19 2 24 2.7% 6.0% P =0.03 OR 0.44 95% CI 0.198 0.960 56% 62% 1.8% 4.6% P =0.04 OR 0.38 95% CI 0.147 0.977 52% 10.6%
Contraception and cancerepidemiological
Contraception and cancerepidemiological evidence Hormonal contraception Combined Progestogen-only Philip C Hannaford University of Aberdeen Breast cancer and combined oral Re-analysis of individual data
Anne H. Calhoun, MD, FAHS Professor of Anesthesiology Professor of Psychiatry
Combined Hormonal Contraceptives & Migraine with Aura Anne H. Calhoun, MD, FAHS Professor of Anesthesiology Professor of Psychiatry University of North Carolina Partner/Co-Founder Carolina Headache Institute
Combined oral contraceptives and risk of venous thromboembolism: nested case control studies using the QResearch and the CPRD databases
Combined oral contraceptives and risk of venous thromboembolism: nested case control studies using the QResearch and the CPRD databases Yana Vinogradova, Carol Coupland, Julia Hippisley-Cox Web appendix:
American Journal of Internal Medicine
American Journal of Internal Medicine 2016; 4(3): 49-59 http://www.sciencepublishinggroup.com/j/ajim doi: 10.11648/j.ajim.20160403.12 ISSN: 2330-4316 (Print); ISSN: 2330-4324 (Online) The Effect of Dose-Reduced
Hormone therapy. Dr. med. Frank Luzuy
Hormone therapy Dr. med. Frank Luzuy Reasons for Initiating/Continuing HT* Menopause-Related Symptoms Osteoporosis, Bone Loss, Fracture Prevention Doctor Prescribed It, Told Me to Take It Cardiovascular
WARNINGS: ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER
DEPO -ESTRADIOL Estradiol cypionate injection, USP WARNINGS: ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens is important. Adequate diagnostic
Title: Low Molecular Weight Heparins (LMWH), fondaparinux (Arixtra)
Origination: 03/29/05 Revised: 09/01/10 Annual Review: 11/20/13 Purpose: To provide guidelines and criteria for the review and decision determination of requests for medications that requires prior authorization.
Causal Inference Framework for Considering the Cardiovascular Risks Associated with Ortho Evra
Causal Inference Framework for Considering the Cardiovascular Risks Associated with Ortho Evra B. Burt Gerstman June 2008 This brief document addresses the question Does Ortho Evra cause more cardiovascular
Menopausal hormone therapy currently has no evidence-based role for
IN PERSPECTIVE HT and CVD Prevention: From Myth to Reality Nanette K. Wenger, M.D. What the studies show, in a nutshell The impact on coronary prevention Alternative solutions Professor of Medicine (Cardiology),
Downloaded from jarums.arums.ac.ir at 10:35 IRST on Friday March 8th ۲۲cm
۱۳۷۸-۷۹ ۲ ﻣﺤﺴﻦ ﺳﻘﺎ ۱ ﻋﻠﻲ ﻧﻌﻤﺘﻲ : ﻨ ۱۰-۱۴ ۶۱۲ ۱۳۷۸-۷۹ ﺷﺎﺧﺺ ﻃﻲ ﻳﻲ : ﻣﻄﺎﻟﻌﻪ ۲۴ ۹ ﻧﺴﺨﻪ SPSS Food Processor : ﻳﺎﻓﺘﻪ ﻫﺎ P
Current Use of Unopposed Estrogen and Estrogen Plus Progestin and the Risk of Acute Myocardial Infarction Among Women With Diabetes
Current Use of Unopposed Estrogen and Estrogen Plus Progestin and the Risk of Acute Myocardial Infarction Among Women With Diabetes The Northern California Kaiser Permanente Diabetes Registry, 1995 1998
BMI and Contraception: What s the Evidence?
BMI and Contraception: What s the Evidence? Kathryn M. Curtis, PhD Division of Reproductive Health Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion
Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception Øjvind Lidegaard, Dr. Med. Sci., Ellen Løkkegaard, Ph.D.,
Diabetologia 9 Springer-Verlag 1992
Diabetologia (1992) 35:967-972 Diabetologia 9 Springer-Verlag 1992 Oral contraceptive use and the risk of Type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women E. B. Rimm,
CURRENT HORMONAL CONTRACEPTION - LIMITATIONS
CURRENT HORMONAL CONTRACEPTION - LIMITATIONS Oral Contraceptives - Features MERITS Up to 99.9% efficacy if used correctly and consistently Reversible method rapid return of fertility Offer non-contraceptive
DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)
DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness
Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)
Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase
Oral contraceptives Epidemiological aspects Øjvind Lidegaard
Oral contraceptives Epidemiological aspects Øjvind Lidegaard Professor Gynaecological Clinic 4232 Rigshospitalet Copenhagen University OC: Epidemiological aspects OC use OC and thrombosis - venous thromboembolism
Epidemiologia e clinica del tromboembolismo venoso. Maria Ciccone Sezione di Ematologia e Fisiopatologia della Coagulazione
Epidemiologia e clinica del tromboembolismo venoso Maria Ciccone Sezione di Ematologia e Fisiopatologia della Coagulazione Thrombophilia may present clinically as one or more of several thrombotic manifestations
Antiplatelet and Anti-Thrombotic Therapy. Ivan Anderson, MD RIHVH Cardiology
Antiplatelet and Anti-Thrombotic Therapy Ivan Anderson, MD RIHVH Cardiology Outline Anti-thrombotic therapy Risk stratification of stroke with atrial fibrillation DVT and PE treatment Pharmacology Anti-platelet
RESEARCH. Susan S Jick, director and senior epidemiologist Rohini K Hernandez, epidemiologist
Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United
Appendix 1. Supplementary Methods
Appendix 1. Supplementary Methods The report on one high-quality study 34 provided only estimates of associations between cervical cancer incidence and IUD use for less than 5 years (versus never) and
KYPHON Balloon Kyphoplasty
KYPHON Results from a randomized controlled study comparing KYPHON to nonsurgical care for treatment of vertebral compression fractures Relief. Mobility. Quality of Life. What is? KYPHON is a minimally
All medications are a double-edged sword with risks
Menopause: The Journal of The North American Menopause Society Vol. 14, No. 5, pp. 1/14 DOI: 10.1097/gme.0b013e31802e8508 * 2007 by The North American Menopause Society REVIEW ARTICLE Postmenopausal hormone
Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus
A Fib & Flutter I48.0 Paroxysmal atrial fibrillation I48.1 Persistent atrial fibrillation I48.2 Chronic atrial fibrillation I48.3 Typical atrial flutter Asthma J45.20 Mild, uncomplicated J45.21 Mild, with
Drug Class Review Newer Oral Anticoagulant Drugs
Drug Class Review Newer Oral Anticoagulant Drugs Final Original Report May 2016 The purpose of reports is to make available information regarding the comparative clinical effectiveness and harms of different
Downloaded from jarums.arums.ac.ir at 18:00 IRDT on Friday March 22nd 2019
٣ ﻣﺠﻴﺪ ﻟﻄﻴﻔﻲ ﻧﻮﻳﺪ ٢ ١ ﺑﺎﺷﺪ ﻳﺎﻓﺘﻪ ﻫﺎ ( ﻣﻴﻠﻲ ﻣﺘﺮ ٢١/٥ ١٩/٧ ( ﻣﻴﻠﻲ ﻣﺘﺮ ١٠٥ ١١١ ١٣ ١٩ ( -١-٢ -٣ ١٣٨١ ﻣﺠﻠﻪ ﻋﻠﻤﻲ ۲۰ ﻣﻘﺪﻣﻪ ٢ ١ ١٩٨٠ ﮔﺎﺳﺘﺮﻳﺖ ﻣ ﺮﻓﺘﻪ ﺑﺎﺷﺪ [١-٥] [۱٠] ﺑﺎﺷﺪ ٣ ﻮ [۷ ۶] ﺑﺎﺷﺪ [۱١] ﻳﻲ VacA ﺗﻮﻛﺴﻴـﻦ ﺑﻪ ﺧﺎﻃﺮ
2016 Physician Quality Reporting System Data Collection Form: Total Knee Replacement
2016 Physician Quality Reporting System Data Collection Form: Total Knee Replacement IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered satisfactory reporting.
N Engl J Med 2018;378: DOI: /NEJMoa Lin, Wan-Ting 2018/06/27
N Engl J Med 2018;378:1200-10. DOI: 10.1056/NEJMoa1710895 Lin, Wan-Ting 2018/06/27 1 Introduction Gout is a chronic illness characterized by hyperuricemia, arthropathy, tophus development, and urolithiasis
Elements for a Public Summary. VI.2.1 Overview of Disease Epidemiology
VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Etonogestrel/ethinylestradiol vaginal delivery system is a vaginal ring form of birth control used to prevent unplanned pregnancy
Quality ID #351: Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation National Quality Strategy Domain: Patient Safety
Quality ID #351: Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
Annals of Internal Medicine
2 May 2000 Volume 132 Number 9 Annals of Internal Medicine Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease The Heart and Estrogen/progestin Replacement Study Deborah Grady,
9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?
Primary Prevention of Heart Disease: What works? What doesn t? Samia Mora, MD, MHS Associate Professor, Harvard Medical School Associate Physician, Brigham and Women s Hospital October 2, 2015 Financial
APPROXIMATELY 38% OF POSTmenopausal
SCIENTIFIC REVIEW AND CLINICAL APPLICATIONS CLINICIAN S CORNER Postmenopausal Hormone Replacement Therapy Scientific Review Heidi D. Nelson, MD, MPH Linda L. Humphrey, MD, MPH Peggy Nygren, MA Steven M.
Elements for a Public Summary. Overview of Disease Epidemiology
VI.2 VI.2.1 Elements for a Public Summary Overview of Disease Epidemiology Etonogestrel/ethinylestradiol vaginal delivery system is a vaginal ring form of birth control used to prevent unplanned pregnancy
study of the effect of birth year
British Journal of Cancer (1997) 75(1), 139-143 1997 Cancer Research Campaign Oral contraceptive use at a young age and the risk of breast cancer: an Icelandic, population-based cohort study of the effect
The New England Journal of Medicine
The New England Journal of Medicine Copyright, 1997, by the Massachusetts Medical Society VOLUME 336 J UNE 19, 1997 NUMBER 25 POSTMENOPAUSAL HORMONE THERAPY AND MORTALITY FRANCINE GRODSTEIN, SC.D., MEIR
Clinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
ORIGINAL INVESTIGATION. Self-Selected Posttrial Aspirin Use and Subsequent Cardiovascular Disease and Mortality in the Physicians Health Study
ORIGINAL INVESTIGATION Self-Selected Posttrial Aspirin Use and Subsequent Cardiovascular Disease and Mortality in the Physicians Health Study Nancy R. Cook, ScD; Patricia R. Hebert, PhD; JoAnn E. Manson,
Regence. Medical Policy Manual. Date of Origin: May Topic: Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment
Regence Medical Policy Manual Topic: Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment Date of Origin: May 2013 Section: Genetic Testing Last Reviewed Date: June 2013
NICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1
The College of Emergency Medicine Patron: HRH The Princess Royal Churchill House Tel +44 (0)207 404 1999 35 Red Lion Square Fax +44 (0)207 067 1267 London WC1R 4SG www.collemergencymed.ac.uk CLINICAL EFFECTIVENESS
Health Numeracy: Explaining risk in numbers patients can use. Kirtly Parker Jones MD
Health Numeracy: Explaining risk in numbers patients can use Kirtly Parker Jones MD Learning Objectives List three different numerical means of presenting risk Describe three graphical methods of presenting
Sex Differences in Stroke Risk and Quality of Life after Stroke
Sex Differences in Stroke Risk and Quality of Life after Stroke Cheryl Bushnell, MD, MHS Associate Professor of Neurology Director, WFB Stroke Center Disclosures Research funding from: World Federation
NQF ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: The Joint Commission Only CMS Voluntary Only
Last Updated: Version 4.4a NQF ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Stroke (STK) Set Measure ID #: Measure Information Form Collected For: The Joint Commission Only CMS
Risk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
Leg blood clots swelling picture
Leg blood clots swelling picture The Borg System is 100 % Leg blood clots swelling picture Signs of a blood clot in your leg include: swelling redness pain; tenderness. These symptoms especially point
THE SAFETY CHECK LIST BEFORE STARTING HT
THE SAFETY CHECK LIST BEFORE STARTING HT This safety checklist was designed by the Endocrine Society in 2015 to minimize the chance of giving hormone therapy to women who may be negatively affected by
COMMENTARY: DATA ANALYSIS METHODS AND THE RELIABILITY OF ANALYTIC EPIDEMIOLOGIC RESEARCH. Ross L. Prentice. Fred Hutchinson Cancer Research Center
COMMENTARY: DATA ANALYSIS METHODS AND THE RELIABILITY OF ANALYTIC EPIDEMIOLOGIC RESEARCH Ross L. Prentice Fred Hutchinson Cancer Research Center 1100 Fairview Avenue North, M3-A410, POB 19024, Seattle,
The Effect of Oral Contraceptive Pills on Haematological Indices Running Title: Haematological Parameters in Oral Contraceptive Users
The Effect of Oral Contraceptive Pills on Haematological Indices Running Title: Haematological Parameters in Oral Contraceptive Users *Sajida S. H. Al-Chalaby, **Sana'a M. Taib, ***Amjad F. Ahmed *Dept.
ORIGINAL INVESTIGATION. Hormone Replacement Therapy and Associated Risk of Stroke in Postmenopausal Women
ORIGINAL INVESTIGATION Hormone Replacement Therapy and Associated Risk of Stroke in Postmenopausal Women Rozenn N. Lemaitre, PhD, MPH; Susan R. Heckbert, MD, PhD; Bruce M. Psaty, MD, PhD; Nicholas L. Smith,
Hormonal contraception and risk of venous thromboembolism: national follow-up study
Hormonal contraception and risk of venous thromboembolism: national follow-up study Øjvind Lidegaard, professor, 1 Ellen Løkkegaard, consultant, 2 Anne Louise Svendsen, statistician, 3 Carsten Agger, data
Report to Supportive Physicians on the Health Effects of Hormonal Contraception. Medical Ethics Council Archdiocese of Kansas City
Report to Supportive Physicians on the Health Effects of Hormonal Contraception Medical Ethics Council Archdiocese of Kansas City Context Contraception is widespread, including among Catholics. Medical
50- and 30-,ug oestrogen preparations
BRITISH MEDICAL JOURNAL 10 MAY 1980 1157 PAPERS AND ORIGINALS Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-,ug oestrogen preparations
Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN (In Press)
Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN 0140-6736 (In Press) Access from the University of Nottingham repository: http://eprints.nottingham.ac.uk/1087/1/lancet_clots_1_20090522_4.pdf
Drug Class Monograph
Drug Class Monograph Class: Oral Anticoagulants Drug: Coumadin (warfarin), Eliquis (apixaban), Pradaxa (dabigatran), Savaysa (edoxaban), arelto (rivaroxaban) Formulary Medications: Eliquis (apixaban),
ORIGINAL INVESTIGATION. An Update on Aspirin in the Primary Prevention of Cardiovascular Disease
ORIGINAL INVESTIGATION An Update on in the Primary Prevention of Cardiovascular Disease Rachel S. Eidelman, MD; Patricia R. Hebert, PhD; Steven M. Weisman, PhD; Charles H. Hennekens, MD, DrPH Background:
PRESCRIBING HORMONAL CONTRACEPTIVES TO WOMEN WITH MIGRAINE (CON) Disclosures. Objectives/Discussion Points 6/2/2017
PRESCRIBING HORMONAL CONTRACEPTIVES TO WOMEN WITH MIGRAINE (CON) Gretchen E. Tietjen, MD Department of Neurology University of Toledo Disclosures Advisory Boards: Eli Lilly, Dr. Reddy s Common Stock: J&J,
Aspirin to Prevent Heart Attack and Stroke: What s the Right Dose?
The American Journal of Medicine (2006) 119, 198-202 REVIEW Aspirin to Prevent Heart Attack and Stroke: What s the Right Dose? James E. Dalen, MD, MPH Professor Emeritus, University of Arizona, Tucson
Counseling and Long-term Follow up After Gestational Disorders
Counseling and Long-term Follow up After Gestational Disorders Tanya Melnik, MD Assistant Professor, University of Minnesota Sarina Martini, MD Ob/Gyn Resident, PGY4 University of Minnesota Counseling
Apixaban for stroke prevention in atrial fibrillation. August 2010
Apixaban for stroke prevention in atrial fibrillation August 2010 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to
Oral Anticoagulation Drug Class Prior Authorization Protocol
Oral Anticoagulation Drug Class Prior Authorization Protocol Line of Business: Medicaid P & T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review
Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute ischemic stroke TOAST classification of, 270 Acute myocardial infarction (AMI) cardioembolic stroke following, 207 208 noncardioembolic
Jeanet M. Kemmeren, Ale Algra, Joost C. M. Meijers, Guido Tans, Bonno N. Bouma, Joyce Curvers, Jan Rosing, and Diederick E.
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized
British Medical Journal. June 3, 2006;332: Patricia M Kearney, Colin Baigent, Jon Godwin, Heather Halls, Jonathan R Emberson, Carlo Patrono
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Metaanalysis of randomised trials 1 British Medical Journal June 3,
Epidemiology of Venous Thromboembolism in the East. Heng Joo NG Department of Haematology Singapore General Hospital Singapore
Epidemiology of Venous Thromboembolism in the East Heng Joo NG Department of Haematology Singapore General Hospital Singapore Early Literature Tinckler LF Br Med J 1964;1:502 Propagating a notion.. Hwang
Anticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar
Anticoagulants and Head Injuries Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar Common Anticoagulants and Indications Coumadin (warfarin) indicated for
Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)
The Microport FIREBIRD Polymer-based Sirolimus- Eluting Stent Clinical Trial Program Update: The FIC and FIREMAN Registries Junbo Ge, MD, FACC, FESC, FSCAI On behalf of Runlin Gao (FIC PI) and Haichang
VTE Risk Assessment. Challenges of Hemostasis in Cancer Patients. Cihan Ay, MD Associate Professor
Challenges of Hemostasis in Cancer Patients VTE Risk Assessment Cihan Ay, MD Associate Professor Clinical Division of Haematology and Haemostaseology Department of Medicine I, Comprehensive Cancer Center
Stroke incidence and case-fatality among Indigenous and non-indigenous populations in the Northern Territory of Australia,
Stroke incidence and case-fatality among Indigenous and non-indigenous populations in the Northern Territory of Australia, 1999 2011 Jiqiong You 1 *, John R. Condon 2, Yuejen Zhao 1, and Steven L. Guthridge
VI.2. ELEMENTS FOR A PUBLIC SUMMARY
VI.2. ELEMENTS FOR A PUBLIC SUMMARY VI.2.1 Overview of Disease Epidemiology COCs containing DRSP-EE are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method
CHOLESTEROL-LOWERING THERAPHY
CHOLESTEROL-LOWERING THERAPHY TRIALS NUMBER OF PARTICIPANTS NUMBER OF WOMEN PERCENTAGE OF WOMEN MEAN AGE MEAN - (YEARS) TRIALS WITH ANALYSIS BY GENDER N, (%) 50,194 15,036 30.0% 60.8 3.2 1/ 6 (16.7%) HR
CAROTID ARTERY ANGIOPLASTY
CAROTID ARTERY ANGIOPLASTY Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline
Norethisterone induced cerebral venous sinus thrombosis (CVST): a rare case report and review of literature
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Ramya T et al. Int J Reprod Contracept Obstet Gynecol. 2014 Mar;3(1):231-235 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
Supplementary Online Content
Supplementary Online Content Huang W-Y, Singer DE, Wu Y-L, et al. Association of intracranial hemorrhage risk with non vitamin K antagonist oral anticoagulant use vs aspirin use: a systematic review and
Landmark Phase III Study of Bayer s Xarelto (Rivaroxaban) Initiated for the Secondary Prevention of Myo
Xarelto (Rivaroxaban) Landmark Phase III Study of Bayer s Xarelto (Rivaroxaban) Initiated for the Secondary Prevention of Myocardial Infarction and Death in Patients with Coronary or Peripheral Artery
Dental Management Considerations for Patients on Antithrombotic Therapy
Dental Management Considerations for Patients on Antithrombotic Therapy Warfarin and Antiplatelet Joel J. Napeñas DDS FDSRCS(Ed) Program Director General Practice Residency Program Department of Oral Medicine
Beyond A1C. Non-glycemic Effects of GLP-1 Receptor Agonists. Olga Astapova MD, PhD Luis Chavez MD URMC Endocrinology Fellows
Beyond A1C Non-glycemic Effects of GLP-1 Receptor Agonists Olga Astapova MD, PhD Luis Chavez MD URMC Endocrinology Fellows Disclosures No conflicts of interest. Learning Objectives 1. Understand the physiological
VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK?
VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK? Ayman El-Menyar (1), MD, Hassan Al-Thani (2),MD (1)Clinical Research Consultant, (2) Head of Vascular Surgery, Hamad General Hospital
Author: K. Ketchum Date: July 2015
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119